NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2021 Wei X, Xie L, Du P, Zhao Z. Impacts of DNA methylation on Tau protein related genes in the brains of patients with Alzheimer's Disease. Neuroscience Letters. 136196. PMID 34437990 DOI: 10.1016/j.neulet.2021.136196   
2021 Rather MA, Khan A, Alshahrani S, Rashid H, Qadri M, Rashid S, Alsaffar RM, Kamal MA, Rehman MU. Inflammation and Alzheimer's Disease: Mechanisms and Therapeutic Implications by Natural Products. Mediators of Inflammation. 2021: 9982954. PMID 34381308 DOI: 10.1155/2021/9982954   
2021 Chuang Y, Van I, Zhao Y, Xu Y. Icariin Ameliorate Alzheimer's Disease by Influencing SIRT1 and Inhibiting Aβ cascade Pathogenesis. Journal of Chemical Neuroanatomy. 102014. PMID 34407393 DOI: 10.1016/j.jchemneu.2021.102014   
2021 Shang Y, Ding S. Flavonoids from Scutellaria baicalensis Georgi Stems and Leaves Regulate the Brain Tau Hyperphosphorylation at M|ultiple Sites Induced by Composited Aβ in Rats. Cns & Neurological Disorders Drug Targets. PMID 34455972 DOI: 10.2174/1871527320666210827112609   
2021 Bai B, Vanderwall D, Li Y, Wang X, Poudel S, Wang H, Dey KK, Chen PC, Yang K, Peng J. Proteomic landscape of Alzheimer's Disease: novel insights into pathogenesis and biomarker discovery. Molecular Neurodegeneration. 16: 55. PMID 34384464 DOI: 10.1186/s13024-021-00474-z   
2021 Armijo E, Edwards G, Flores A, Vera J, Shahnawaz M, Moda F, Gonzalez C, Sanhueza M, Soto C. Induced Pluripotent Stem Cell-Derived Neural Precursors Improve Memory, Synaptic and Pathological Abnormalities in a Mouse Model of Alzheimer's Disease. Cells. 10. PMID 34359972 DOI: 10.3390/cells10071802   
2021 Sharma C, Kim SR. Linking Oxidative Stress and Proteinopathy in Alzheimer's Disease. Antioxidants (Basel, Switzerland). 10. PMID 34439479 DOI: 10.3390/antiox10081231   
2021 Uddin MS, Kabir MT, Jalouli M, Rahman MA, Jeandet P, Behl T, Alexiou A, Albadrani GM, Abdel-Daim MM, Perveen A, Ashraf GM. Neuroinflammatory Signaling in the Pathogenesis of Alzheimer's Disease. Current Neuropharmacology. PMID 34525932 DOI: 10.2174/1570159X19666210826130210   
2021 Setti SE, Reed MN. Network activity changes in the pathophysiology of Alzheimer's disease: the role of aging and early entorhinal cortex dysfunction. Metabolic Brain Disease. PMID 34591222 DOI: 10.1007/s11011-021-00848-8   
2021 Sharma A, Anand JS, Kumar Y. Immunotherapeutics for AD: A Work in Progress. Cns & Neurological Disorders Drug Targets. PMID 34477533 DOI: 10.2174/1871527320666210903101522   
2021 Zhang Z, Yang X, Song YQ, Tu J. Autophagy in Alzheimer's Disease Pathogenesis: Therapeutic Potential and Future Perspectives. Ageing Research Reviews. 101464. PMID 34551326 DOI: 10.1016/j.arr.2021.101464   
2021 Preeti K, Sood A, Fernandes V. Metabolic Regulation of Glia and Their Neuroinflammatory Role in Alzheimer's Disease. Cellular and Molecular Neurobiology. PMID 34515874 DOI: 10.1007/s10571-021-01147-7   
2021 Wang H, Zhang Y, Zheng C, Yang S, Chen X, Wang H, Gao S. A 3-Gene-Based Diagnostic Signature in Alzheimer's Disease. European Neurology. 1-8. PMID 34521086 DOI: 10.1159/000518727   
2021 Tijms BM, Gobom J, Teunissen C, Dobricic V, Tsolaki M, Verhey F, Popp J, Martinez-Lage P, Vandenberghe R, Lleó A, Molinuévo JL, Engelborghs S, Freund-Levi Y, Froelich L, Bertram L, et al. CSF Proteomic Alzheimer's Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative Individuals. Proteomes. 9. PMID 34449748 DOI: 10.3390/proteomes9030036   
2021 Mahdiabadi S, Momtazmanesh S, Perry G, Rezaei N. Immune modulations and immunotherapies for Alzheimer's disease: a comprehensive review. Reviews in the Neurosciences. PMID 34506700 DOI: 10.1515/revneuro-2021-0092   
2021 Kaur D, Behl T, Chigurupati S, Sehgal A, Singh S, Sharma N, Badavath VN, Vargas-De-La-Cruz C, Bhatia S, Al-Harrasi A, Dey A, Aleya L, Bungau S. Deciphering the focal role of endostatin in Alzheimer's disease. Environmental Science and Pollution Research International. PMID 34561808 DOI: 10.1007/s11356-021-16567-7   
2021 Qiu S, Palavicini JP, Wang J, Gonzalez NS, He S, Dustin E, Zou C, Ding L, Bhattacharjee A, Van Skike CE, Galvan V, Dupree JL, Han X. Adult-onset CNS myelin sulfatide deficiency is sufficient to cause Alzheimer's disease-like neuroinflammation and cognitive impairment. Molecular Neurodegeneration. 16: 64. PMID 34526055 DOI: 10.1186/s13024-021-00488-7   
2021 Sun Y, Xu S, Jiang M, Liu X, Yang L, Bai Z, Yang Q. Role of the Extracellular Matrix in Alzheimer's Disease. Frontiers in Aging Neuroscience. 13: 707466. PMID 34512308 DOI: 10.3389/fnagi.2021.707466   
2021 Ledreux A, Thomas S, Hamlett ED, Trautman C, Gilmore A, Rickman Hager E, Paredes DA, Margittai M, Fortea J, Granholm AC. Small Neuron-Derived Extracellular Vesicles from Individuals with Down Syndrome Propagate Tau Pathology in the Wildtype Mouse Brain. Journal of Clinical Medicine. 10. PMID 34501378 DOI: 10.3390/jcm10173931   
2021 Luo R, Fan Y, Yang J, Ye M, Zhang DF, Guo K, Li X, Bi R, Xu M, Yang LX, Li Y, Ran X, Jiang HY, Zhang C, Tan L, et al. A novel missense variant in ACAA1 contributes to early-onset Alzheimer's disease, impairs lysosomal function, and facilitates amyloid-β pathology and cognitive decline. Signal Transduction and Targeted Therapy. 6: 325. PMID 34465723 DOI: 10.1038/s41392-021-00748-4   
2021 Li S, Wang C, Wang Z, Tan J. Involvement of cerebrovascular abnormalities in the pathogenesis and progression of Alzheimer's disease: an adrenergic approach. Aging. 13. PMID 34479211 DOI: 10.18632/aging.203482   
2021 Festa BP, Barbosa AD, Rob M, Rubinsztein DC. The pleiotropic roles of autophagy in Alzheimer's disease: From pathophysiology to therapy. Current Opinion in Pharmacology. 60: 149-157. PMID 34419832 DOI: 10.1016/j.coph.2021.07.011   
2021 Ibanez L, Cruchaga C, Fernández MV. Advances in Genetic and Molecular Understanding of Alzheimer's Disease. Genes. 12. PMID 34440421 DOI: 10.3390/genes12081247   
2021 Gu J, Li Z, Chen H, Xu X, Li Y, Gui Y. Neuroprotective Effect of Trans-Resveratrol in Mild to Moderate Alzheimer Disease: A Randomized, Double-Blind Trial. Neurology and Therapy. PMID 34402024 DOI: 10.1007/s40120-021-00271-2   
2021 Cardona K, Medina J, Orrego-Cardozo M, Restrepo de Mejía F, Elcoroaristizabal X, Naranjo Galvis CA. Inflammatory gene expression profiling in peripheral blood from patients with Alzheimer's disease reveals key pathways and hub genes with potential diagnostic utility: a preliminary study. Peerj. 9: e12016. PMID 34484988 DOI: 10.7717/peerj.12016   
2021 Hernández AE, García E. Mesenchymal Stem Cell Therapy for Alzheimer's Disease. Stem Cells International. 2021: 7834421. PMID 34512767 DOI: 10.1155/2021/7834421   
2021 Herring WL, Gould IG, Fillit H, Lindgren P, Forrestal F, Thompson R, Pemberton-Ross P. Predicted Lifetime Health Outcomes for Aducanumab in Patients with Early Alzheimer's Disease. Neurology and Therapy. PMID 34426940 DOI: 10.1007/s40120-021-00273-0   
2021 Zhong J, Ren X, Liu W, Wang S, Lv Y, Nie L, Lin R, Tian X, Yang X, Zhu F, Liu J. Discovery of Novel Markers for Identifying Cognitive Decline Using Neuron-Derived Exosomes. Frontiers in Aging Neuroscience. 13: 696944. PMID 34512304 DOI: 10.3389/fnagi.2021.696944   
2021 Argueti-Ostrovsky S, Alfahel L, Kahn J, Israelson A. All Roads Lead to Rome: Different Molecular Players Converge to Common Toxic Pathways in Neurodegeneration. Cells. 10. PMID 34572087 DOI: 10.3390/cells10092438   
2021 Utz J, Berner J, Muñoz LE, Oberstein TJ, Kornhuber J, Herrmann M, Maler JM, Spitzer P. Cerebrospinal Fluid of Patients With Alzheimer's Disease Contains Increased Percentages of Synaptophysin-Bearing Microvesicles. Frontiers in Aging Neuroscience. 13: 682115. PMID 34295239 DOI: 10.3389/fnagi.2021.682115   
2021 Russell JC, Lei H, Chaliparambil RK, Fish S, Markiewicz SM, Lee TI, Noori A, Kaeberlein M. Generation and characterization of a tractable C. elegans model of tauopathy. Geroscience. PMID 34536202 DOI: 10.1007/s11357-021-00436-9   
2021 Singh CSB, Choi KB, Munro L, Wang HY, Pfeifer CG, Jefferies WA. Reversing pathology in a preclinical model of Alzheimer's disease by hacking cerebrovascular neoangiogenesis with advanced cancer therapeutics. Ebiomedicine. 71: 103503. PMID 34534764 DOI: 10.1016/j.ebiom.2021.103503   
2021 Gupta GL, Samant NP. Current druggable targets for therapeutic control of Alzheimer's disease. Contemporary Clinical Trials. 106549. PMID 34464763 DOI: 10.1016/j.cct.2021.106549   
2021 Gkanatsiou E, Nilsson J, Toomey CE, Vrillon A, Kvartsberg H, Portelius E, Zetterberg H, Blennow K, Brinkmalm A, Lashley T, Brinkmalm G. Amyloid pathology and synaptic loss in pathological aging. Journal of Neurochemistry. PMID 34473357 DOI: 10.1111/jnc.15487   
2021 Wightman DP, Jansen IE, Savage JE, Shadrin AA, Bahrami S, Holland D, Rongve A, Børte S, Winsvold BS, Drange OK, Martinsen AE, Skogholt AH, Willer C, Bråthen G, Bosnes I, ... , et al. A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease. Nature Genetics. 53: 1276-1282. PMID 34493870 DOI: 10.1038/s41588-021-00921-z   
2021 Brenowitz WD, Xiang Y, McEvoy CT, Yang C, Yaffe K, Le WD, Leng Y. Current Alzheimer disease research highlights: evidence for novel risk factors. Chinese Medical Journal. PMID 34507318 DOI: 10.1097/CM9.0000000000001706   
2021 Nisa FY, Rahman MA, Hossen MA, Khan MF, Khan MAN, Majid M, Sultana F, Haque MA. Role of neurotoxicants in the pathogenesis of Alzheimer's disease: a mechanistic insight. Annals of Medicine. 53: 1476-1501. PMID 34433343 DOI: 10.1080/07853890.2021.1966088   
2021 Singh R, Kaur N, Dhingra N, Kaur T. Protein misfolding, ER Stress and Chaperones: An approach to develop chaperone-based therapeutics for Alzheimer's Disease. The International Journal of Neuroscience. 1-32. PMID 34402740 DOI: 10.1080/00207454.2021.1968859   
2021 Cheng C, Reis SA, Adams ET, Fass DM, Angus SP, Stuhlmiller TJ, Richardson J, Olafson H, Wang ET, Patnaik D, Beauchamp RL, Feldman DA, Silva MC, Sur M, Johnson GL, et al. High-content image-based analysis and proteomic profiling identifies Tau phosphorylation inhibitors in a human iPSC-derived glutamatergic neuronal model of tauopathy. Scientific Reports. 11: 17029. PMID 34426604 DOI: 10.1038/s41598-021-96227-5   
2021 Kaur D, Behl T, Sehgal A, Singh S, Sharma N, Badavath VN, Ul Hassan SS, Hasan MM, Bhatia S, Al-Harassi A, Khan H, Bungau S. Unravelling the potential neuroprotective facets of erythropoietin for the treatment of Alzheimer's disease. Metabolic Brain Disease. PMID 34436747 DOI: 10.1007/s11011-021-00820-6   
2021 Yin X, Qiu Y, Zhao C, Zhou Z, Bao J, Qian W. The Role of Amyloid-Beta and Tau in the Early Pathogenesis of Alzheimer's Disease. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 27: e933084. PMID 34471085 DOI: 10.12659/MSM.933084   
2021 Grundman J, Spencer B, Sarsoza F, Rissman RA. Transcriptome analyses reveal tau isoform-driven changes in transposable element and gene expression. Plos One. 16: e0251611. PMID 34587152 DOI: 10.1371/journal.pone.0251611   
2021 Wu M, Liu CZ, Barrall EA, Rissman RA, Joiner WJ. Unbalanced regulation of α7 nAChRs by Ly6h and NACHO contributes to neurotoxicity in Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 34446574 DOI: 10.1523/JNEUROSCI.0494-21.2021   
2021 Dai S, Zhou F, Sun J, Li Y. NPD1 Enhances Autophagy and Reduces Hyperphosphorylated Tau and Amyloid-β42 by Inhibiting GSK3β Activation in N2a/APP695swe Cells. Journal of Alzheimer's Disease : Jad. PMID 34602482 DOI: 10.3233/JAD-210729   
2021 Rahman MA, Hannan MA, Uddin MJ, Rahman MS, Rashid MM, Kim B. Exposure to Environmental Arsenic and Emerging Risk of Alzheimer's Disease: Perspective Mechanisms, Management Strategy, and Future Directions. Toxics. 9. PMID 34437506 DOI: 10.3390/toxics9080188   
2021 Chong JR, Ashton NJ, Karikari TK, Tanaka T, Schöll M, Zetterberg H, Blennow K, Chen CP, Lai MKP. Blood-based high sensitivity measurements of beta-amyloid and phosphorylated tau as biomarkers of Alzheimer's disease: a focused review on recent advances. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 34510001 DOI: 10.1136/jnnp-2021-327370   
2021 Li X, Zhang X, Xing R, Qi F, Dong J, Li D, Tian X, Yu B, Huang M, Zhang L, Yuan X, Yang Y, Wu H, Zang L, Mao X, et al. Syringic acid demonstrates promising protective effect against tau fibrillization and cytotoxicity through regulation of endoplasmic reticulum stress-mediated pathway as a prelude to Alzheimer's disease. International Journal of Biological Macromolecules. PMID 34599991 DOI: 10.1016/j.ijbiomac.2021.09.173   
2021 Chen SD, Lu JY, Li HQ, Yang YX, Jiang JH, Cui M, Zuo CT, Tan L, Dong Q, Yu JT, . Staging tau pathology with tau PET in Alzheimer's disease: a longitudinal study. Translational Psychiatry. 11: 483. PMID 34537810 DOI: 10.1038/s41398-021-01602-5   
2021 Phillips JS, Nitchie FJ, Da Re F, Olm CA, Cook PA, McMillan CT, Irwin DJ, Gee JC, Dubroff JG, Grossman M, Nasrallah IM, . Rates of longitudinal change in F-flortaucipir PET vary by brain region, cognitive impairment, and age in atypical Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 34515411 DOI: 10.1002/alz.12456   
2021 Shahbaz SK, Koushki K, Sathyapalan T, Majeed M, Sahebkar A. PLGA-Based Curcumin Delivery System: An Interesting Therapeutic Approach in Treatment of Alzheimer's Disease. Current Neuropharmacology. PMID 34429054 DOI: 10.2174/1570159X19666210823103020